During the past decade, Consultants of Clinical Research, Ohio GI and Liver Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Consultants of Clinical Research, Ohio GI and Liver Institute" are "Hepatitis C" (2 trials). Many other conditions were trialed in "Consultants of Clinical Research, Ohio GI and Liver Institute" in a lesser frequency.

Most popular intervention types in "Consultants of Clinical Research, Ohio GI and Liver Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "CTS-1027" (2 trials), "Pegylated interferon" (1 trials), "Placebo for ribavirin" (1 trials), "Ribavirin" (1 trials) and "ribavirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Consultants of Clinical Research, Ohio GI and Liver Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Consultants of Clinical Research, Ohio GI and Liver Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Consultants of Clinical Research, Ohio GI and Liver Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Consultants of Clinical Research, Ohio GI and Liver Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".